BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16754296)

  • 1. Non-invasive cancer detection: strategies for the identification of novel cancer markers.
    Sorio C; Mauri P; Pederzoli P; Scarpa A
    IUBMB Life; 2006 Apr; 58(4):193-8. PubMed ID: 16754296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour markers.
    Pandha HS; Waxman J
    QJM; 1995 Apr; 88(4):233-41. PubMed ID: 7540924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of tumour markers in cancer diagnosis and treatment.
    Higgins C
    Nurs Times; 1996 Apr 17-23; 92(16):36-7. PubMed ID: 8710591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biologic markers of cancer. Towards a selective use for the detection and surveillance of malignant tumors].
    Bellet D; Bidart JM
    Rev Prat; 1989 Nov; 39(26):2350-4. PubMed ID: 2480633
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tumor markers].
    Cohen AD; Cohen Y
    Harefuah; 1993 Oct; 125(7-8):243-6. PubMed ID: 7693557
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer biomarkers: knowing the present and predicting the future.
    Chatterjee SK; Zetter BR
    Future Oncol; 2005 Feb; 1(1):37-50. PubMed ID: 16555974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for prostate cancer detection.
    Parekh DJ; Ankerst DP; Troyer D; Srivastava S; Thompson IM
    J Urol; 2007 Dec; 178(6):2252-9. PubMed ID: 17936845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular markers of prostate cancer.
    Bradford TJ; Tomlins SA; Wang X; Chinnaiyan AM
    Urol Oncol; 2006; 24(6):538-51. PubMed ID: 17138135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced proteomic technologies for cancer biomarker discovery.
    Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
    Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery.
    Hu S; Yen Y; Ann D; Wong DT
    Drug Discov Today; 2007 Nov; 12(21-22):911-6. PubMed ID: 17993408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
    Sardana G; Jung K; Stephan C; Diamandis EP
    J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic strategies for biomarker identification: progress and challenges.
    Fung ET; Wright GL; Dalmasso EA
    Curr Opin Mol Ther; 2000 Dec; 2(6):643-50. PubMed ID: 11249741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for the early detection of cancer: an inflammatory concept.
    Roy HK; Khandekar JD
    Arch Intern Med; 2007 Sep; 167(17):1822-4. PubMed ID: 17893302
    [No Abstract]   [Full Text] [Related]  

  • 14. CE-based simultaneous liquid-phase noncompetitive enzyme immunoassay for three tumor markers in human serum using electrochemical detection.
    Zhang S; Li X; Zhang F
    Electrophoresis; 2007 Dec; 28(23):4427-34. PubMed ID: 17979157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced detection systems for enzyme-linked heterogeneous immunoassays: luminescence.
    Edwards JC; Moon CR
    Immunol Ser; 1990; 53():95-106. PubMed ID: 1713073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic approaches in lung cancer biomarker development.
    Cho JY; Sung HJ
    Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.
    Kulasingam V; Diamandis EP
    Nat Clin Pract Oncol; 2008 Oct; 5(10):588-99. PubMed ID: 18695711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor markers].
    Cappelaere P
    Rev Prat; 1988 Jun; 38(17):1058-63. PubMed ID: 2457249
    [No Abstract]   [Full Text] [Related]  

  • 19. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of accessible human cancer biomarkers using ex vivo chemical proteomic strategies.
    Kischel P; Waltregny D; Castronovo V
    Expert Rev Proteomics; 2007 Dec; 4(6):727-39. PubMed ID: 18067412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.